当前位置： SCI文献检索 > CHEST期刊下所有文献 > Evaluation of intravascular hemolysis with erythrocyte creatine in patients with cardiac valve prostheses.

Evaluation of intravascular hemolysis with erythrocyte creatine in patients with cardiac valve prostheses.

Abstract：

STUDY OBJECTIVES:To detect intravascular hemolysis in patients with cardiac valve prostheses. Erythrocyte creatine, a marker of erythrocyte age that increases with shortening erythrocyte survival, was evaluated with other hemolytic markers and hemodynamic parameters. DESIGN:Prospective study. PATIENTS AND MEASUREMENTS:Erythrocyte creatine was enzymatically assayed in 33 patients with prosthetic valves, including 15 patients with aortic valve replacement, 13 patients with mitral valve replacement, and 5 patients with double-valve (aortic and mitral) replacement, and 33 control subjects. Blood flow velocity and valvular regurgitation were determined by Doppler echocardiography. Other hemolytic markers (lactate dehydrogenase [LDH], reticulocyte count, and haptoglobin) and cardiac muscle markers (myoglobin and myosin light chain 1) were also measured. RESULTS:Erythrocyte creatine and LDH levels were significantly higher (p < 0.0001) and the haptoglobin level was lower (p < 0.0001) in patients with a prosthetic valve as compared with control subjects. However, there were no significant differences in these markers between those with (n = 17) and without (n = 16) regurgitation. Patients with high erythrocyte creatine levels (> 1.8 micro mol/g hemoglobin) exhibited significantly higher total peak flow velocity (sum of peak flow velocities at mitral and aortic valves) than those with normal erythrocyte creatine levels (p = 0.006). Erythrocyte creatine had a significant correlation with total peak flow velocity (r = 0.64, p < 0.0001), but LDH and haptoglobin had no significant correlation with total peak flow velocity. Patients with high LDH levels (> 460 IU/L) showed significantly higher myoglobin (p = 0.008) and myosin light chain 1 (p = 0.02) than those with normal LDH levels, whereas erythrocyte creatine was not related to cardiac muscle markers. CONCLUSIONS:Erythrocyte creatine is a quantitative and reliable marker for intravascular hemolysis in patients with prosthetic valves. Mild hemolysis is ascribable to valvular flow velocity rather than regurgitation.

journal_name

Chest

journal_title

Chest

authors

Okumiya T,Ishikawa-Nishi M,Doi T,Kamioka M,Takeuchi H,Doi Y,Sugiura T

doi

10.1378/chest.125.6.2115

subject

Has Abstract

pub_date

2004-06-01 00:00:00

pages

2115-20

issue

eissn

0012-3692

issn

1931-3543

pii

S0012-3692(16)58984-3

journal_volume

125

pub_type

杂志文章

在线工具

Evaluation of intravascular hemolysis with erythrocyte creatine in patients with cardiac valve prostheses.